Noindex: medium evidence

Piperonylic Acid

CAS 94-53-1

Piperonylic Acid (CAS 94-53-1) is a pharmaceutical compound with 3 bioactivity targets and 0 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
3
SOURCE DrugCentral
Adverse signals
0
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Piperonylic Acid
CAS Number
94-53-1
UNII
QX3V1NO0KH
InChIKey
VDVJGIYXDVPQLP-UHFFFAOYSA-N
ChEMBL ID
CHEMBL573781
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
natural product
SOURCE EMBL-EBI ChEMBL 3 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

TargetActivity ValueAssaysOrganism
- IC50 46650.87333333333 nM 2 -
- Potency 29881.649999999998 nM 2 -
- IC50 18.4 % 1 -
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Piperonylic Acid used for in pharmaceutical contexts?

Piperonylic Acid (CAS 94-53-1) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Piperonylic Acid?

No adverse-event association or SIDER side-effect rows are rendered for Piperonylic Acid in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Piperonylic Acid also used in cosmetics?

No same-CAS cosmetics profile is rendered from the ingredients-table cross-reference for Piperonylic Acid.

What clinical phase is Piperonylic Acid in?

No phase 1-4 clinical development badge is rendered for Piperonylic Acid because the matched compound identifier rows do not contain a max-phase value.